GlassScriptPhysician profile
David M Laird
NPI 1376548503
$3,626.96
in general payments reported to CMS, 2019-2025
30 companies · $368 in 2025
The $368 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,616 · 2020: $117 · 2021: $305 · 2022: $387 · 2023: $360 · 2024: $473 · 2025: $368.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,157 · Education: $44.69.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,157.43 |
| Education | $44.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Silk Road Medical, INC. | $1,093.76 | 2019-2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| Endologix LLC | $523.61 | 2019-2020 | |
| Allergan, INC. | $263.94 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $242.08 | 2022-2025 | Gattex |
| Medtronic, INC. | $230.23 | 2022-2024 | Nim Vital |
| Abbvie INC. | $198.55 | 2023-2025 | |
| Livanova USA, INC. | $121.80 | 2025 | Vns Therapy Sentiva Model 1000 Generator |
| Lemaitre Vascular, INC. | $96.15 | 2019-2023 | Flexcel Carotid Shunt |
| Intuitive Surgical, INC. | $89.99 | 2022 | |
| W. L. Gore & Associates, INC. | $87.07 | 2019-2025 | Gore Bio-A Tissue Reinforcement, Gore Synecor Biomaterial, Gore Synecor Preperitoneal Biomaterial |
| Pacira Pharmaceuticals Incorporated | $73.63 | 2024-2025 | Exparel |
| Merit Medical Systems INC | $68.68 | 2025 | Savi Scout |
| Bolton Medical INC | $59.78 | 2023 | Treo Abdominal Stent-Graft System |
| Tela Bio, INC. | $56.08 | 2023-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Venclose INC. | $53.76 | 2020 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $50.76 | 2023 | Lynparza, Keytruda |
| Artivion, INC. | $48.92 | 2019-2020 | |
| Innocoll Pharmaceuticals Limited | $39.32 | 2021-2022 | |
| Boston Scientific Corporation | $30.93 | 2019-2023 | Spyglass |
| Kerecis Limited | $24.82 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Smith+Nephew, INC. | $21.08 | 2019 | |
| Ambu INC. | $20.42 | 2022 | |
| Z-Medica, LLC | $20.26 | 2020 | |
| Enterra Medical, INC. | $19.68 | 2024 | |
| Tactile Systems Technology INC | $19.45 | 2021 | |
| Endogastric Solutions, INC | $18.80 | 2022 | |
| Myriad Genetic Laboratories, INC. | $16.51 | 2023 | Myrisk |
| Shire North American Group INC | $16.22 | 2019 | |
| Osiris Therapeutics INC. | $12.66 | 2019 | |
| Microline Surgical INC | $8.02 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Laird listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.